Observational, Prospective Single-Center Study of Antibiotic Prophylaxis with High-Dose Cefoxitin in Bariatric Surgery
Author(s) -
Thibaut Belveyre,
Philippe Guerci,
Elise Pape,
Nathalie Thilly,
Kossar Hosseini,
Laurent Brunaud,
Nicolas Gambier,
Claude Meistelman,
Marie-Reine Losser,
Julien Birckener,
Julien ScalaBertola,
Emmanuel Novy
Publication year - 2019
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01613-19
Subject(s) - cefoxitin , medicine , observational study , antibiotic prophylaxis , antibiotics , surgery , single center , prospective cohort study , staphylococcus aureus , microbiology and biotechnology , biology , bacteria , genetics
The optimal dose of cefoxitin for antibiotic prophylaxis in obese patients remains uncertain. We evaluated the adequacy of a 4-gram dosing regimen of cefoxitin against the most frequent pathogens that infect patients undergoing bariatric surgery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom